Related Experiment Video
Updated: Jul 11, 2025
12:24
Murine Model of CD40-activation of B cells
Published on: March 5, 2010
12.7K
CD40/CD40L expression and its prognostic value in cervical cancer
G A Grazia1,2, D R Bastos1,2, L L Villa1,2
1Departamento de Radiologia e Oncologia, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brasil.
Summary
CD40 and CD40L proteins are highly expressed in squamous cervical carcinomas, offering potential as prognostic markers. This finding suggests improved survival rates for patients with higher expression of these immune-related molecules.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- CD40, a tumor necrosis factor receptor (TNFR) family member, regulates immune responses and antitumor activity.
- CD40 is expressed on various immune and cancer cells, including those in cervical, breast, and melanoma cancers.
Purpose of the Study:
- To investigate CD40 and CD40L transcriptional and protein levels in cervical cancer.
- To evaluate the association of CD40/CD40L expression with cervical cancer subtypes and patient survival.
Main Methods:
- Analysis of CD40/CD40L expression in cervical cancer cell lines and tumor tissues.
- Utilizing public datasets to examine CD40/CD40L expression in different cervical tumor subtypes.
- Correlating CD40/CD40L expression with overall survival data.
Main Results:
- CD40 expression was higher in squamous cell carcinoma cell lines compared to adenocarcinomas.
- Approximately 83% of squamous cell carcinomas expressed CD40 in public datasets.
- Elevated CD40 and CD40L expression in squamous cervical carcinomas correlated with better overall survival.
Conclusions:
- CD40 and CD40L are significantly expressed in squamous cervical carcinomas.
- These proteins show potential as prognostic biomarkers for cervical cancer.
- Further exploration of CD40/CD40L as prognostic markers in cervical cancer is warranted.
